海南自贸港“零关税”药械进口货值超2.2亿元

Core Viewpoint - The implementation of the "zero tariff" policy for imported drugs and medical devices in Hainan Free Trade Port has significantly reduced costs and improved access to advanced medical products for patients and healthcare institutions [1][2]. Group 1: Policy Impact - The "zero tariff" policy has led to an import value of 225 million yuan and a tax exemption of 29.47 million yuan, supporting the development of Hainan's healthcare industry [1]. - The policy allows eligible medical institutions, higher education institutions, and pharmaceutical research institutes to import certain drugs and medical devices without tariffs and VAT, effectively lowering operational costs [2]. Group 2: Patient Benefits - The policy has reduced the financial burden on patients by eliminating import tariffs (approximately 3%) and VAT (13%) on medical devices and drugs, making advanced medical products more affordable [2]. - For example, the import of a specialized medical device valued at 1.5 million yuan can save approximately 195,000 yuan under the "zero tariff" policy, while a diabetes treatment drug valued at 50,000 yuan can save nearly 6,000 yuan [2]. Group 3: Customs Facilitation - The official launch of customs operations will allow "zero tariff" imports to enter Hainan more freely, with simplified customs procedures reducing the number of declaration items from 105 to 33 [3]. - This facilitation measure is designed to expedite the clearance of goods that do not require inspection or special permits, further reducing costs for market participants [3].